Drugs News and Research

RSS

Study estimates hepatitis C infection seroprevalence in pregnant women

Researchers estimate the seroprevalence of hepatitis C virus in pregnant women globally and in World Health Organization-specific regions.

22 Nov 2023

Study finds among outpatients with mild to moderate COVID-19, treatment with fluvoxamine does not reduce duration of symptoms

Researchers investigate the effects of high-dose fluvoxamine among patients with mild-to-moderate COVID-19.

22 Nov 2023

Nitrite analysis in pharmaceuticals: monitoring a precursor to nitrosamine

...

From Metrohm Middle East FZC 22 Nov 2023

Researchers discover way to reverse brain aging caused by COVID-19

University of Queensland researchers have found a way to reverse a cellular process triggered by COVID-19 that contributes to premature aging of the brain.

22 Nov 2023

Combined application of therapeutic viruses and nanomaterials to revolutionize cancer therapy

Using oncolytic viruses (OVs) in combination with nanomaterials as a novel approach to cancer treatment.

22 Nov 2023

From hospital to hospitality: Spin doctors brand getting sick as an adventure. It’s not.

The last time I stepped on a plane for vacation, for fun, was more than three years ago. I haven't been able to visit California, whose coast I adore. Nor Rome, where my husband and I lived for some time.

22 Nov 2023

Drug for children with achondroplasia may help reduce chances of SIDS

A drug that boosts bone growth in children with the most common form of dwarfism, may also reduce their chances of sudden infant death syndrome, sleep apnea and needing surgery, according to a new study.

21 Nov 2023

Immunotherapy drug is safe and may benefit overall survival for patients with advanced NSCLC

For patients with advanced or metastatic non-small cell lung cancer (NSCLC) and limited performance status, an immune checkpoint inhibitor drug called durvalumab is safe and may benefit overall survival, according to a new eClinicalMedicine study by UPMC Hillman Cancer Center researchers.

21 Nov 2023

Pitt researcher receives $1.95 million grant to study cell communication

Day by day, we communicate with our office colleagues to accomplish tasks that are necessary to function.

21 Nov 2023

Researchers discover new option to target the metastatic capacity of melanoma cells

As an extremely aggressive form of skin cancer, cutaneous melanoma is still associated with a high mortality rate. Enormous progress has recently been made in the fight against deadly metastasis, but existing therapeutic measures are still not effective in many cases.

21 Nov 2023

Out for blood? For routine lab work, the hospital billed her $2,400

Reesha Ahmed was on cloud nine. It was January and Ahmed was at an OB-GYN's office near her home in Venus, Texas, for her first prenatal checkup.

21 Nov 2023

Evolving overdose crisis shakes previously effective treatments

"You can't inject a horse tranquilizer and think nothing bad is gonna happen" to you, said Ty Sears, 33, a longtime drug user now in recovery.

21 Nov 2023

Experts recommend genomics for tackling antimicrobial resistance, outline key strategies for effective surveillance

The Lancet Microbe article summarizes discussions by the Surveillance and Epidemiology of Drug-resistant Infections Consortium on using genomics for antimicrobial resistance surveillance, highlighting its benefits and challenges and providing key recommendations for effective implementation.

20 Nov 2023

New study links DNA methylation in GLP1R gene to obesity without metabolic disorders

The study investigates the role of epigenetic changes in GLP1R gene polymorphisms on metabolically healthy obesity (MHO), revealing that apart from genetic variations, DNA methylation significantly influences the occurrence of MHO.

20 Nov 2023

Study highlights glycolysis as a potential therapeutic target to combat Mycobacterium tuberculosis

It has been uncertain how Mycobacterium tuberculosis deflects the immune response in humans, though evidence has pointed to host immunometabolism - the intrinsic link between metabolism in immune cells and their immune function.

20 Nov 2023

Study highlights rise in pain medication dependence due to medical negligence

Dependence on pain medication is on the rise due to lack of vigilance by medical professionals, according to a new study from the University of Surrey.

20 Nov 2023

New method for capturing proteins in nano-sized traps could revolutionize disease research

Proteins that form clumps occur in many difficult-to-treat diseases, such as ALS, Alzheimer's, and Parkinson's.

20 Nov 2023

AI-based approach uncovers social patterns that impact child health outcomes

A team led by researchers at Weill Cornell Medicine has used an AI-based approach to uncover underlying patterns among the conditions in which people are born, grow, live, work, and age, termed social determinants of health (SDoH), and then linked each pattern to children's health outcomes.

20 Nov 2023

Amalus Therapeutics develops innovative approach for treating patients with cancer or fibrotic diseases

Ghent University and the booming Ghent biotech landscape welcome a brand new spin-off: Amalus Therapeutics is developing a new class of drugs that selectively target corrupt fibroblast cells.

20 Nov 2023

Breakthroughs in TB prevention offer hope for children

Taking a common antibiotic could more than half the risk of children becoming sick with multidrug resistant tuberculosis (MDR-TB), according to findings presented this week at a conference on lung health.

20 Nov 2023

Drugs News and Research

Study estimates hepatitis C infection seroprevalence in pregnant women

Study finds among outpatients with mild to moderate COVID-19, treatment with fluvoxamine does not reduce duration of symptoms

Nitrite analysis in pharmaceuticals: monitoring a precursor to nitrosamine

Researchers discover way to reverse brain aging caused by COVID-19

Combined application of therapeutic viruses and nanomaterials to revolutionize cancer therapy

From hospital to hospitality: Spin doctors brand getting sick as an adventure. It’s not.

Drug for children with achondroplasia may help reduce chances of SIDS

Immunotherapy drug is safe and may benefit overall survival for patients with advanced NSCLC

Pitt researcher receives $1.95 million grant to study cell communication

Researchers discover new option to target the metastatic capacity of melanoma cells

Out for blood? For routine lab work, the hospital billed her $2,400

Evolving overdose crisis shakes previously effective treatments

Experts recommend genomics for tackling antimicrobial resistance, outline key strategies for effective surveillance

New study links DNA methylation in GLP1R gene to obesity without metabolic disorders

Study highlights glycolysis as a potential therapeutic target to combat Mycobacterium tuberculosis

Study highlights rise in pain medication dependence due to medical negligence

New method for capturing proteins in nano-sized traps could revolutionize disease research

AI-based approach uncovers social patterns that impact child health outcomes

Amalus Therapeutics develops innovative approach for treating patients with cancer or fibrotic diseases

Breakthroughs in TB prevention offer hope for children

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News